Heterologous expression and activity of α-helical antimicrobial peptide SW in Bacillus subtilis

Abstract

The antimicrobial peptide Cecropin P1 (CP1) was isolated from the pig-intestinal parasitic nematode Ascaris lumbricoides and had potent antimicrobial activity. However, its cytotoxicity is high. Herein, Using CP1 as the parent peptide, we designed a derivative peptide SW by replacing amino acids based on the structure and function relationship of antimicrobial peptides (AMPs) to reduce the toxicity of CP1. Subsequently, the gene sequence encoding SacB-6 ×His-SUMO-SW was constructed into the recombinant expression vector PHY-P43 of Bacillus subtilis WB800N. The fusion proteins with concentrations of 26.97 mg/L were obtained after purification by a Ni–NTA column. A total of 5.37 mg of SW was obtained from 1 L fermentation cultures. Recombinant SW (rSW) exhibits potent antimicrobial activity against gram-negative bacteria by inducing membrane instabilities. In addition, rSW showed low hemolytic activity and cytotoxicity against human red blood cells and IPEC-J2, respectively. In the mice model of peritonitis infection, rSW could reduce Escherichia coli-loading in the liver, spleen, lung, and kidney of mice. These results indicate that rSW production by Bacillus. subtilis is a safe and reliable strategy, and rSW has the potential to be a novel antimicrobial agent against gram-negative bacterial infections.